Shinobu Shimizu

Nagoya, 4668560, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Intravenously delivered multilineage-differentiating stress-enduring cells dampen hyperoxia-induced lung injury in a rat model with features of bronchopulmonary dysplasia.

Intravenously delivered multilineage-differentiating stress-enduring cells dampen hyperoxia-induced lung injury in a rat model with features of bronchopulmonary dysplasia.

Journal: Stem cell research & therapy

Published: October 16, 2025

Biomarkers for early detection and monitoring of abnormal brain development in mild fetal growth restriction.

Biomarkers for early detection and monitoring of abnormal brain development in mild fetal growth restriction.

Journal: iScience

Published: April 07, 2025

Novel stem cell therapy for cerebral palsy using stem cells from human exfoliated deciduous teeth.

Novel stem cell therapy for cerebral palsy using stem cells from human exfoliated deciduous teeth.

Journal: Stem cell research & therapy

Published: February 05, 2025

Randomised, double-blind study to evaluate the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A clinical trial protocol.

Randomised, double-blind study to evaluate the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A clinical trial protocol.

Journal: PloS one

Published: November 28, 2024

Safety and tolerability of a Muse cell-based product in neonatal hypoxic-ischemic encephalopathy with therapeutic hypothermia (SHIELD trial).

Safety and tolerability of a Muse cell-based product in neonatal hypoxic-ischemic encephalopathy with therapeutic hypothermia (SHIELD trial).

Journal: Stem cells translational medicine

Published: February 28, 2024

Systemic administration of clinical-grade multilineage-differentiating stress-enduring cells ameliorates hypoxic-ischemic brain injury in neonatal rats.

Systemic administration of clinical-grade multilineage-differentiating stress-enduring cells ameliorates hypoxic-ischemic brain injury in neonatal rats.

Journal: Scientific reports

Published: January 19, 2023

Mexiletine in spinal and bulbar muscular atrophy: a randomized controlled trial.

Mexiletine in spinal and bulbar muscular atrophy: a randomized controlled trial.

Journal: Annals of clinical and translational neurology

Published: August 07, 2022

Safety and tolerability of a multilineage-differentiating stress-enduring cell-based product in neonatal hypoxic-ischaemic encephalopathy with therapeutic hypothermia (SHIELD trial): a clinical trial protocol open-label, non-randomised, dose-escalation trial.

Safety and tolerability of a multilineage-differentiating stress-enduring cell-based product in neonatal hypoxic-ischaemic encephalopathy with therapeutic hypothermia (SHIELD trial): a clinical trial protocol open-label, non-randomised, dose-escalation trial.

Journal: BMJ open

Published: April 27, 2022

Protocol for a Phase 1, Open-Label, Multiple-Center, Dose-Escalation Study to Evaluate the Safety and Tolerability of ADR-001 in the Treatment of Immunoglobulin A Nephropathy.

Protocol for a Phase 1, Open-Label, Multiple-Center, Dose-Escalation Study to Evaluate the Safety and Tolerability of ADR-001 in the Treatment of Immunoglobulin A Nephropathy.

Journal: Frontiers in medicine

Published: February 24, 2022

Safety and efficacy of MIKE-1 in patients with advanced pancreatic cancer: a study protocol for an open-label phase I/II investigator-initiated clinical trial based on a drug repositioning approach that reprograms the tumour stroma.

Safety and efficacy of MIKE-1 in patients with advanced pancreatic cancer: a study protocol for an open-label phase I/II investigator-initiated clinical trial based on a drug repositioning approach that reprograms the tumour stroma.

Journal: BMC cancer

Published: November 30, 2021

Influence of background characteristics in responders of regenerative therapy by periurethral injection of adipose-derived regenerative cells for male stress urinary incontinence.

Influence of background characteristics in responders of regenerative therapy by periurethral injection of adipose-derived regenerative cells for male stress urinary incontinence.

Journal: Lower urinary tract symptoms

Published: November 06, 2021

Survey Results and Recommendations from Japanese Stakeholders for Good Clinical Practice Renovation.

Survey Results and Recommendations from Japanese Stakeholders for Good Clinical Practice Renovation.

Journal: Therapeutic innovation & regulatory science

Published: September 15, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026